← Back to headlines
AbbVie signs pain drug licensing deal with China’s Haisco
Pharmaceutical giant AbbVie has entered into a licensing agreement with China's Haisco for a pain drug, expanding its presence in the Chinese market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
